Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic...

36
Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory

Transcript of Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic...

Page 1: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Iron Overload in Chronic Anaemias

Dick Wells MD, DPhil, FRCPCDirector, Crashley Myelodysplastic Syndrome Research Laboratory

Page 2: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Preview

• Why we need iron

• The iron economy

• Why too much iron is a bad thing

• Pumping (out) iron

• Current recommendations for treatment of iron overload in MDS

Page 3: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Why we need iron

• Enzymes

• Oxygen transport– Haemoglobin (red blood cells)– Myoglobin (muscle cells)

• About 70% of the body’s iron is in these proteins

Page 4: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

The iron economy

Page 5: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

The iron economy is well-balanced.

70%

30%

Page 6: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

We cope well with iron shortage…

• Iron deficiency is the most common deficiency state in the world– Blood loss– dietary

• About 1000 mg of iron is stored as ferritin (1/3 of total body iron)

• Intestinal absorption of iron increases in response to deficiency

Page 7: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

…but poorly with iron excess.

• Iron is excreted by shedding of intestinal cells

• There is no physiologic mechanism to excrete excessive iron

Page 8: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Blood transfusion overwhelms the iron balance

• Normal daily iron flux:

1-2 mg

• Each unit of PRBC:

200-250 mg200-250 mg

Page 9: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Summary: Iron is in a fine balance

• In normal circumstances, not much iron enters or leaves the body

• The body cannot increase its excretion of iron.

• Blood transfusions contain much iron, so patients who need frequent transfusions will build up excess iron.

Page 10: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Why too much iron is a bad thing

Page 11: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Dying RBC

Reticuloendothelial System

Free Iron

Liver

Heart

Endocrine organsCIRRHOSIS

ARRHYTHMIA HEART FAILURE

DIABETES

Page 12: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Lessons from thalassaemia

Page 13: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

When does iron become a problem?

• Normally 2.5 – 3 grams of iron in the body.

• Tissue damage when total body iron is 7 – 15 grams– After 30-50 units of red blood cells

Page 14: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

How do we know if there’s too much iron?

• Serum ferritin concentration– Used in clinical practice globally

• Liver biopsy– Reference methodology (‘gold standard’)

• Magnetic resonance imaging (MRI)– Investigational, potential for broad access

• Magnetic susceptometry (SQUID)– Investigational, very limited access

Page 15: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Serum Ferritin Concentration• Easy

• Inexpensive

• Can be tricky – not purely iron – Inflammation (acute phase reactant)– Liver function abnormalities

• Not perfect marker in iron overload– What it lacks in accuracy it makes up for in part

with world-wide availability

Page 16: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Liver Biopsy

LIC = Liver iron concentration.Reprinted with permission from Angelucci E, et al. N Engl J Med. 2000;343:327-331.

25 patients with iron overload andcirrhosis

1 mg dry weight liver sample

Hepatic iron concentration, mg/g dry weight

To

tal

bo

dy

iro

n s

tore

s, m

g/k

g

0 5 10 15 20 25

300

250

200

150

100

50

0

r = 0.98

• LIC accurately reflects total body iron stores

Page 17: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Magnetic Susceptometry (SQUID)

• Superconducting QUantum Interference Device– High-power magnetic field– Iron interferes with the field– Changes in the field are detected

• Noninvasive, sensitive, and accurate

• Limited availability– Superconductor requires high

maintenance– Only 4 machines worldwide

Photograph courtesy of A. Piga

Page 18: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Magnetic Resonance Imaging

Bright = high iron concentration; dark areas = low iron concentration

Page 19: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Summary: Too much iron is bad

• Iron overload caused by transfusions causes malfunction of the liver, heart, and endocrine organs.

• Problems may begin after 30 units of RBC (or even earlier)

• We use serum ferritin level to estimate iron levels– MRI might be better

Page 20: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Iron chelation

Out

Page 21: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

MetalChelatorChelator + ChelatorChelator

Toxic Non-Toxic

“Chelate”

Outsidethe

BodyMetal

What is Chelation Therapy?

Page 22: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

How to chelate?

• Currently licensed in Canada:– Deferoxamine

• Alternatives– Deferiprone (L1)

• Available on compassionate release

– Deferasirox (ICL670, Exjade)• Undergoing accelerated review by Health Canada

Page 23: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Deferoxamine: Mode of Action

Page 24: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Challenges of Deferoxamine

• Subcutaneous/Intravenous route of administration– Expensive– Cumbersome– Uncomfortable

• Rapid metabolism (30 minute half-life) necessitates prolonged infusion (12-15 hours)

• Complications due to iron overload still occur due to poor compliance with therapy

Page 25: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Deferoxamine infusion

Page 26: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Common Side Effects of Deferoxamine

• Local reactions– Erythema (localized redness)– Induration (localized swelling)– Pruritus (itchiness)

• Ophthalmologic– Reduced visual acuity– Impaired color vision– Night blindness– Increased by presence of diabetes

• Hearing loss• Zinc deficiency

Page 27: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Are we certain it helps?Survival of patients with thalassaemia

Page 28: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Summary: Iron chelation and deferoxamine

• Chelation works by attaching a drug to iron, which allows the body to excrete it.

• Deferoxamine is awful stuff…– Inconvenient and uncomfortable to take– Many nasty side effects

• …but it works– Enormous extension of lifespan in

thalassaemia.

Page 29: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

ICL670: Deferasirox, Exjade

Oral, dispersible tablet Taken once daily Highly specific for iron Chelated iron

excreted mainly in faeces

Less than 10% excreted in the urine

Page 30: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

ICL670 works.

Deferoxamine < 25 25-35 35-50 ≥ 50ICL670 5 10 20 30

All doses in mg/kg/day

-3000

-2000

-1000

0

1000

2000

3000

4000

Desferal 0107

ICL670 0107

ICL670 0108

g/L

Deferoxamine 0107

ICL670 0107

ICL670 0108

Page 31: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

ICL670 is Generally Tolerable The most common adverse events were mild and

transient:– Nausea (10%)– Vomiting (9%)– Abdominal pain (14%)– Diarrhea (12%)– Skin rash (8%)

Rarely required discontinuation of study drug Mild increases in serum creatinine No agranulocytosis observed

Page 32: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

When can we have Exjade?

• Already FDA-approved in the USA

• Health Canada approval expected September 2006

• Provincial formularies will need to decide whether to include Exjade.

Page 33: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

What do the experts say?

Page 34: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Recommended Treatment for Iron Overload in MDS

• Why: to prevent end-organ complications of iron overload and extend lifespan

• Whom: transfusion-dependent patients with expected survival > 1 year

• When: after 25 units RBC transfused, ferritin >1000.

• How: Desferal by subcutaneous infusion (for now); keep ferritin<1000

Page 35: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Summary

• Iron overload is an inevitable consequence of chronic RBC transfusion

• Iron toxicity affects the function of the liver, heart, and endocrine organs

• Chelation therapy should be offered to iron overloaded patients with life expectancy >1 year

• Desferal is the only drug currently available; Exjade will be available soon.

Page 36: Iron Overload in Chronic Anaemias Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory.

Thank you!